We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


GATC Offers Sequencing with 454 Technology

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "GATC Offers Sequencing with 454 Technology"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:

GATC has announced that it is now offering genome sequencing using the sequencing technology of 454 Life Sciences.

This makes GATC the largest commercial sequencing service provider in Europe with a total capacity of 15.6 giga bases per year.
Only by combining the traditional Sanger technology with the 454 technology, can genomes now be sequenced and analysed in half the usual project time, with a considerable reduction in the number of contigs and gaps.

The technology can also be employed for many other applications, e.g. for sequencing of whole transcriptomes in a single run or for in-depth mutation analysis of rare mutations at much lower costs.
"We believe that the 454 technology is an important step towards a new era of DNA sequencing," says Peter Pohl, CEO of GATC Biotech AG.

"We are very excited to be the first service provider in Europe who offers considerable time and cost advantages to the customers by integrating this innovative technology and combining it with the traditional Sanger method."